These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2447679)

  • 61. A cytotoxic monoclonal IgM antibody (Tü 101) directed against an antigenic determinant shared between the HLA-A allospecificities A2 and A28.
    Müller C; Liangru S; Schneider M; Ziegler A; Wernet P
    Hum Immunol; 1983 Apr; 6(4):189-97. PubMed ID: 6188732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
    van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
    Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cross-reacting bacterial determinants in ankylosing spondylitis.
    Sullivan JS; Prendergast JK; Geczy AF; Edmonds JP; McGuigan LE; Edwards CM
    Am J Med; 1988 Dec; 85(6A):54-5. PubMed ID: 2462351
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monoclonal antibody to HLA-A3.
    Berger AE; Davis JE; Cresswell P
    Hybridoma; 1982; 1(2):87-90. PubMed ID: 6208124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular mimicry in Reiter's syndrome: cytotoxicity and ELISA studies of HLA-microbial relationships.
    Inman RD; Chiu B; Johnston ME; Falk J
    Immunology; 1986 Jul; 58(3):501-6. PubMed ID: 3488263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gamma ray-induced mutants as a tool for the production and characterisation of monoclonal antibodies against HLA-alloantigens.
    Spring B; Pawelec G; Ziegler A
    Tissue Antigens; 1986 Apr; 27(4):201-8. PubMed ID: 3014680
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunochemical variants of HLA-B27.
    Kaneoka H; Engleman EG; Grumet FC
    J Immunol; 1983 Mar; 130(3):1288-92. PubMed ID: 6600481
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
    Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
    Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of the structure of HLA-Bw47 to HLA-B13 and its relationship to 21-hydroxylase deficiency.
    Zemmour J; Ennis PD; Parham P; Dupont B
    Immunogenetics; 1988; 27(4):281-7. PubMed ID: 3257938
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies.
    Ebringer A; Ghuloom M
    Ann Rheum Dis; 1986 Aug; 45(8):703-4. PubMed ID: 3488716
    [No Abstract]   [Full Text] [Related]  

  • 73. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
    Parham P
    J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
    Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R
    Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes.
    Fuller AA; Rodey GE; Parham P; Fuller TC
    Hum Immunol; 1990 Jul; 28(3):306-25. PubMed ID: 1695624
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A monoclonal antibody directed against the HLA-Bw6 epitope.
    Radka SF; Kostyu DD; Amos DB
    J Immunol; 1982 Jun; 128(6):2804-6. PubMed ID: 6176653
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis).
    Møller P; Vinje O; Berg K
    Clin Genet; 1982 Mar; 21(3):215-21. PubMed ID: 6980067
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA-B27 phenotyping with flow cytometry: further improvement by multiple monoclonal antibodies.
    Hoffmann JJ; Janssen WC
    Clin Chem; 1997 Oct; 43(10):1975-81. PubMed ID: 9342021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monoclonal antibodies against an HLA-B27-derived peptide react with an epitope present on bacterial proteins.
    Raybourne RB; Williams KM
    J Immunol; 1990 Oct; 145(8):2539-44. PubMed ID: 1698856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.